Table 3.
Unadjusted analysis (n=717)
|
Adjusted analysis (n=717)
|
|||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p Value | |
Age | 0.97 | 0.96–0.99 | 0.003 | 0.97 | 0.95–0.99 | 0.005 |
Sex (female) | 0.80 | 0.42–1.54 | 0.50 | 0.74 | 0.38–1.44 | 0.38 |
Current smoking | 1.15 | 0.75–1.75 | 0.52 | 1.16 | 0.75–1.79 | 0.49 |
Current glucocorticoid treatment | 1.70 | 0.92–3.15 | 0.09 | 2.18 | 1.13–4.21 | 0.02 |
Family history of osteoporosis in first degree relative | 1.21 | 0.84–1.74 | 0.31 | 1.23 | 0.83–1.83 | 0.30 |
Prior fragility fracture | 0.82 | 0.56–1.19 | 0.25 | 1.07 | 0.70–1.62 | 0.77 |
DXA results | ||||||
Osteoporosis | 0.93 | 0.64–1.37 | 0.73 | 0.96 | 0.57–1.61 | 0.85 |
Osteopenia | 0.84 | 0.59–1.20 | 0.34 | 0.80 | 0.51–1.27 | 0.35 |
Normal BMD | 1.34 | 0.89–2.02 | 0.16 | 1.25 | 0.79–1.97 | 0.35 |
All variables in the table are included in the adjusted analysis